Skip to main content

Advertisement

SpringerLink
Log in

Prognosis of surgically resected lung cancer with extremely high preoperative serum carcinoembryonic antigen level

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to investigate the prognosis of resected lung cancer patients with extremely high carcinoembryonic antigen (CEA) levels. Several reports have indicated that increased preoperative serum CEA levels are associated with a dismal outcome after surgery, whereas others have reported long-term survival among patients with extremely high preoperative CEA levels. We investigated whether preoperative serum CEA levels, especially extremely high levels, were related to the prognosis of non-small-cell lung cancer (NSCLC) after surgery.

Methods

From September 1996 to January 2008, a total of 649 patients underwent surgical treatment for NSCLC at Juntendo University Hospital. We conducted a retrospective review to investigate the prognostic significance of the preoperative CEA level in these patients. We also investigated the prognosis of patients with an extremely high preoperative CEA level (>30 ng/ml).

Results

The 5-year survival rates were 78.4% and 63.0% for patients with normal and abnormal preoperative CEA levels, respectively. The survival rate was significantly worse for patients with abnormal preoperative CEA levels (P = 0.0002). In all, 28 patients had preoperative CEA levels >30 ng/ml. Although most of these patients showed a poor prognosis, 7 (25.0%) were longterm survivors (>4 years).

Conclusion

An abnormal preoperative CEA level suggests a poor prognosis for patients with NSCLC after surgery. Nevertheless, a few patients with an extremely high preoperative CEA level had long-term survival. Even if the preoperative CEA is extremely high, we perform a careful survey for distant or intrathoracic metastases and should not overlook operable cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P, Levasseur P. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 1994;58:811–814.

    Article  PubMed  CAS  Google Scholar 

  2. Concannon JP, Dalbow MH, Hodgson SE, Headings JJ, Markopoulos E, Mitchell J, et al. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 1978;42:1477–1483.

    Article  PubMed  CAS  Google Scholar 

  3. Sobin LH, Wittekind C. International Union Against Cancer: TNM classification of malignant tumours. 6th edn. New York: Wiley-Liss; 2002.

    Google Scholar 

  4. World Health Organization. WHO histological typing of lung and pleural tumors. 3rd edn. New York: Springer; 1999.

    Google Scholar 

  5. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Prognostic significance of perioperative serum CEA in NSCLC: analysis of 1000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004;78:216–221.

    Article  PubMed  Google Scholar 

  6. Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, et al. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg 2007;83:419–424.

    Article  PubMed  Google Scholar 

  7. Sakao Y, Tomimatsu S, Takeda Y, Natsuaki M, Itoh T. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 2004;25:520–522.

    Article  PubMed  Google Scholar 

  8. Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, et al. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 2007;32:440–444.

    Article  PubMed  Google Scholar 

  9. Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:435–439.

    Article  PubMed  Google Scholar 

  10. Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H, et al. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002;74:174–179.

    Article  PubMed  Google Scholar 

  11. Tomita M, Matsuzaki Y, Edogawa M, Shimizu T, Hara M, Onitsuka T. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg. 2004;10:76–80.

    PubMed  Google Scholar 

  12. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y. Clinical predictor of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J. Thorac Cardiovasc Surg 1999;117:593–598.

    Article  PubMed  CAS  Google Scholar 

  13. Takamochi K, Nagai K, Suzuki K, Yoshida J, Ohde Y, Nishiwaki Y. Clinical predictor of N2 disease in non-small cell lung cancer. Chest 2000;117:1577–1582.

    Article  PubMed  CAS  Google Scholar 

  14. Dent PB, McCulloch PB, Wesley-James O, MacLaren R, Muirhead W, Dunnett CW. Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer 1978;42:1484–1491.

    Article  PubMed  CAS  Google Scholar 

  15. Vincent RG, Chu TM, Fergen TB, Ostrander M. Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer 1975;36:2069–2076.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Thoracic Surgery, Juntendo University School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan

    Nobumasa Takahashi, Kenji Suzuki, Kazuya Takamochi & Shiaki Oh

Authors
  1. Nobumasa Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenji Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuya Takamochi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shiaki Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobumasa Takahashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, N., Suzuki, K., Takamochi, K. et al. Prognosis of surgically resected lung cancer with extremely high preoperative serum carcinoembryonic antigen level. Gen Thorac Cardiovasc Surg 59, 699–704 (2011). https://doi.org/10.1007/s11748-011-0797-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-011-0797-x

Key words

Search

Navigation